Advertisement

Topics

Astellas Pharma Acquires Quethera

10:38 EDT 10 Aug 2018 | Drug Discovery Development

Through this transaction, Astellas has acquired Quethera's ophthalmic gene therapy program.
Contributed Author: 
Astellas Pharma Inc.

Original Article: Astellas Pharma Acquires Quethera

NEXT ARTICLE

More From BioPortfolio on "Astellas Pharma Acquires Quethera"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...